Aviva’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.5M | Buy |
323,823
+8,749
| +3% | +$383K | 0.03% | 452 |
|
|
2025
Q4 | $12.2M | Buy |
315,074
+16,741
| +6% | +$638K | 0.02% | 511 |
|
|
2025
Q3 | $10.5M | Buy |
298,333
+17,754
| +6% | +$643K | 0.02% | 524 |
|
|
2025
Q2 | $10.1M | Buy |
280,579
+17,377
| +7% | +$576K | 0.02% | 522 |
|
|
2025
Q1 | $8.19M | Buy |
263,202
+34,133
| +15% | +$1.08M | 0.02% | 490 |
|
|
2024
Q4 | $5.84M | Buy |
229,069
+214,946
| +1,522% | +$5.7M | 0.02% | 514 |
|
|
2024
Q3 | $400K | Sell |
14,123
-48
| -0.3% | -$1.33K | ﹤0.01% | 838 |
|
|
2024
Q2 | $374K | Hold |
14,171
| – | – | ﹤0.01% | 864 |
|
|
2024
Q1 | $430K | Buy |
14,171
+177
| +1% | +$5.22K | ﹤0.01% | 887 |
|
|
2023
Q4 | $393K | Hold |
13,994
| – | – | ﹤0.01% | 898 |
|
|
2023
Q3 | $380K | Sell |
13,994
-53
| -0.4% | -$1.57K | ﹤0.01% | 911 |
|
|
2023
Q2 | $432K | Sell |
14,047
-4,983
| -26% | -$169K | ﹤0.01% | 895 |
|
|
2023
Q1 | $686K | Sell |
19,030
-30,939
| -62% | -$1.15M | ﹤0.01% | 904 |
|
|
2022
Q4 | $1.97M | Sell |
49,969
-1,048
| -2% | -$43.7K | 0.01% | 707 |
|
|
2022
Q3 | $2.05M | Sell |
51,017
-24,109
| -32% | -$1.03M | 0.01% | 699 |
|
|
2022
Q2 | $3.16M | Sell |
75,126
-8,223
| -10% | -$337K | 0.02% | 678 |
|
|
2022
Q1 | $3.25M | Buy |
83,349
+32,894
| +65% | +$1.29M | 0.02% | 686 |
|
|
2021
Q4 | $2.01M | Sell |
50,455
-4,952
| -9% | -$192K | 0.01% | 865 |
|
|
2021
Q3 | $2M | Sell |
55,407
-48,472
| -47% | -$1.88M | 0.01% | 752 |
|
|
2021
Q2 | $4.26M | Buy |
103,879
+1,560
| +2% | +$66.4K | 0.02% | 635 |
|
|
2021
Q1 | $4.46M | Buy |
102,319
+68,469
| +202% | +$3.25M | 0.02% | 559 |
|
|
2020
Q4 | $1.69M | Buy |
+33,850
| New | +$1.44M | 0.01% | 719 |
|
Other funds holding RPRX
